ATROPINE SULFATE; EDROPHONIUM CHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for atropine sulfate; edrophonium chloride and what is the scope of freedom to operate?
Atropine sulfate; edrophonium chloride
is the generic ingredient in one branded drug marketed by Mylan and Mylan Institutional, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.Summary for ATROPINE SULFATE; EDROPHONIUM CHLORIDE
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 2 |
NDAs: | 2 |
DailyMed Link: | ATROPINE SULFATE; EDROPHONIUM CHLORIDE at DailyMed |
US Patents and Regulatory Information for ATROPINE SULFATE; EDROPHONIUM CHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan | ENLON-PLUS | atropine sulfate; edrophonium chloride | INJECTABLE;INJECTION | 019678-001 | Nov 6, 1991 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan Institutional | ENLON-PLUS | atropine sulfate; edrophonium chloride | INJECTABLE;INJECTION | 019677-001 | Nov 6, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ATROPINE SULFATE; EDROPHONIUM CHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mylan | ENLON-PLUS | atropine sulfate; edrophonium chloride | INJECTABLE;INJECTION | 019678-001 | Nov 6, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
Mylan Institutional | ENLON-PLUS | atropine sulfate; edrophonium chloride | INJECTABLE;INJECTION | 019677-001 | Nov 6, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |